Different types of assays led to different results in measures of factor IX variant FIX-R338L, the authors found. A new field study could help clinicians better interpret laboratory measurements of ...
Hemophilia A and B are X-linked bleeding disorders characterized by partial or complete absence of clotting factors VIII and IX (FVIII and FIX, respectively). FVIII and FIX are critical coagulation ...
A commercially prepared plasma concentrate was administered in six infusions to four patients with factor IX deficiency. All showed a distinct rise in the factor IX level. On the basis of the ...
Major safety issues to be addressed here include the risk of formation of inhibitory antibodies to the transgene product, which can block treatment by conventional protein therapy, and the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results